HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders.

Abstract
Proteins of the ProSAP/Shank family act as major organizing scaffolding elements within the postsynaptic density of excitatory synapses. Deletions, mutations or the downregulation of these molecules has been linked to autism spectrum disorders, the related Phelan McDermid Syndrome or Alzheimer's disease. ProSAP/Shank proteins are targeted to synapses depending on binding to zinc, which is a prerequisite for the assembly of the ProSAP/Shank scaffold. To gain insight into whether the previously reported assembly of ProSAP/Shank through zinc ions provides a crossing point between genetic forms of autism spectrum disorder and zinc deficiency as an environmental risk factor for autism spectrum disorder, we examined the interplay between zinc and ProSAP/Shank in vitro and in vivo using neurobiological approaches. Our data show that low postsynaptic zinc availability affects the activity dependent increase in ProSAP1/Shank2 and ProSAP2/Shank3 levels at the synapse in vitro and that a loss of synaptic ProSAP1/Shank2 and ProSAP2/Shank3 occurs in a mouse model for acute and prenatal zinc deficiency. Zinc-deficient animals displayed abnormalities in behaviour such as over-responsivity and hyperactivity-like behaviour (acute zinc deficiency) and autism spectrum disorder-related behaviour such as impairments in vocalization and social behaviour (prenatal zinc deficiency). Most importantly, a low zinc status seems to be associated with an increased incidence rate of seizures, hypotonia, and attention and hyperactivity issues in patients with Phelan-McDermid syndrome, which is caused by haploinsufficiency of ProSAP2/Shank3. We suggest that the molecular underpinning of prenatal zinc deficiency as a risk factor for autism spectrum disorder may unfold through the deregulation of zinc-binding ProSAP/Shank family members.
AuthorsStefanie Grabrucker, Linda Jannetti, Matti Eckert, Simone Gaub, Resham Chhabra, Stefanie Pfaender, Katharina Mangus, Parameshwar Pasham Reddy, Vladan Rankovic, Michael J Schmeisser, Michael R Kreutz, Günter Ehret, Tobias M Boeckers, Andreas M Grabrucker
JournalBrain : a journal of neurology (Brain) Vol. 137 Issue Pt 1 Pg. 137-52 (Jan 2014) ISSN: 1460-2156 [Electronic] England
PMID24277719 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Psap protein, mouse
  • RNA, Small Interfering
  • Saposins
  • Zinc
Topics
  • Animals
  • Attention Deficit Disorder with Hyperactivity (physiopathology)
  • Behavior, Animal (physiology)
  • Blotting, Western
  • Cells, Cultured
  • Child Development Disorders, Pervasive (metabolism, physiopathology)
  • Chromosome Deletion
  • Chromosome Disorders (metabolism, physiopathology)
  • Chromosomes, Human, Pair 22 (metabolism)
  • Female
  • Hippocampus (metabolism)
  • Humans
  • Immunohistochemistry
  • Mice
  • Organ Culture Techniques
  • Pregnancy
  • RNA, Small Interfering (genetics)
  • Rats
  • Real-Time Polymerase Chain Reaction
  • Saposins (metabolism)
  • Spectrometry, Fluorescence
  • Synapses (physiology)
  • Transfection
  • Vocalization, Animal (physiology)
  • Zinc (deficiency)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: